Hepatitis C virus infection in the elderly

QJM: An International Journal of Medicine

Volumn 89, Issue 4, 1996, Pages 291-296

  Brind, A M ^a   Watson, J P ^a   James, O F W ^a   Bassendine, M F ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ABDOMINAL PAIN; AGED; ARTICLE; BLOOD TRANSFUSION; CHRONIC HEPATITIS; CLINICAL ARTICLE; EDEMA; FEMALE; GENOTYPE; HEALTH CARE PERSONNEL; HEMODIALYSIS; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALAISE; MALE; MILITARY SERVICE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; RISK FACTOR; SYMPTOM; TATTOO; VARICOSIS;

EID: 0029960888     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.4.291     Document Type: Article

References (23)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-62.
2. Irving WL, Neal KR, Underwood JCE, Simmonds PN, James V, on behalf of Trent Regional Hepatitis C Virus Study Group. Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Lancet 1994; 308:695-6.
3. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Cut 1993; 34 (suppl.):S13-16.
4. Sirchia G, Almini D, Bellobuono A, Giovanetti AM, Marconi M, Mercuriali F, Mozzi F, Parravicini A, Pizzi M, Zanuso F. Prevalence of hepatitis C virus in Italian blood donors. The Italian Cooperative Group. Vox Sang 1990; 59:26-9.
5. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327:1899-905.
6. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis C. N Engl J Med 1995; 332:1463-6.
7. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ. Interrelationship of blood transfusion, non-A, non B Hepatitis and Hepatocellular Carcinoma: Analysis by detection of antibody to Hepatitis C virus. Hepatology 1990; 12:671-5.
8. Seeff LB, Bussell-Bales Z, Wright EC, et al. Long-term mortality after transfusion associated non-A, non-B hepatitis. N Engl J Med 1992; 327:1906-11.
9. Gordon SC, Elloway RS, Long JC, Muchowski D. The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs intravenous drug use. Hepatology 1993; 18:1338-44.
10. Stuyer L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol 1994; 74:1093-102.
11. Watson JP, Brind AM, Chapman CE, Bates CL, Gould FK, Johnson SJ, Burt AD, Ferguson J, Simmonds P, Bassendine MF. Hepatitis C virus: Epidemiology and Genotypes in North East of England. Gut 1996; 38:269-76.
12. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16:293-9.
13. Pol S, Thiers V, Nousbaum J-B, Legendre Ch, Bertholet P, Kreis H, Brechot C. Changing distribution of HCV genotypes in the last decades. J Hepatol 1994; 21:S13.
14. Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, Beilobuono A, Mondelli M. Molecular epidemiology of hepatitis infection among intravenous drug users. J Hepatol 1995; 22:691-5.
15. Keehn RJ. Follow-up studies of World War II and Korean conflict prisoners III. Mortality to January 1976. Am J Epidemiol 1980; 111:194-211.
16. Gill GV, Selkon JB, Mortimer PP, Vandervelde EM. Hepatitis B infection in former prisoners of the Japanese. Lancet 1980; 2:918.
17. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic Hepatitis B and C: A prospective study of 251 patients. Hepatology 1995; 21:650-5.
18. Ueda T, Ohita K, Suzuki N, Yamaguchi M, Hirai K, Horiachi T, Wantanbe JM, Miyamoto T, Ito K. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992; 146:266-8.
19. Irving WL, Day S, Johnston ID. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis 1993; 148:1683-4.
20. Ferri C, Caracciolo F, Zignello AL, Civita LL, Monti M, Longombardo C, Lombardini F, Greco F, Capochiani E, Mazzoni A. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88:393-4.
21. Poynard T, Bedoosa P, Chevallier M, Mathwin P, Lemonnier C, Trepo C, Couzigou P, Payer JL, Sajus M, Costa JM, Vidaud M, Caput JC and the Multi Study Group. A comparison of three Interferon alpha-2b regimens for the longterm treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332:1457-62.
22. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 364:1051-5.
23. Shiell A, Briggs A, Farrell GC. The cost effectiveness of alpha interferon in the treatment of chronic hepatitis C. Med J Aust 1994; 160:268-72.